Pawel Lewicki

Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL.

Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL.

Part of Surgalign Holdings, Inc., Inteneural Networks, Inc. is a medical high-tech company based in Chicago, IL. The company specializes in AI and big data learning analysis of brain imaging. The company is developing Sigmund AI™?, an artificial intelligence-based anatomical segmentation and analytics software platform designed for central nervous system imaging (MRI, MRA, CT, CT-angio). Inteneural Networks was founded in 2017 by Pawel Lewicki, a pioneer in data mining and big data learning, and Krzysztof Siemionow, a surgeon who specializes in high-tech imaging databases and surgical applications. Inteneural Networks was acquired by Surgalign Holdings, Inc. on January 05, 2022 for $20.93 million.